About us

iXLife is a private investment firm focused on emerging life sciences companies.  iXLife was created with the mission to invest in and catalyze the development of breakthrough therapies and products based on landmark life science discoveries.  With $55 million under management, our investment portfolio includes therapeutic and diagnostic companies, with currently all portfolio companies based in France.   

iXLife is backed by the iXCore group, a 500+ employee, global organization that develops and markets advanced-technology navigation systems for commercial and military applications, with an annual turnover of more than $100 million.  iXCore was founded by the leadership team that founded Photonetics, a fiber optical technology provider that was acquired for $1.05 billion in what remains one of the largest acquisitions in France.   

iXLife collaborates with management teams to build innovative life science companies, by applying the same success factors used with Photonetics and iXCore technology companies.